| Structure of the human apo TFIIH | |
Heteromer P18074; P32780; P51948; Q13888; Q13889; Q6ZYL4; Q92759; | 30-728 | 100.0 | 1×SF4; 6×ZN; |
|
| Human holo-PIC in the closed state | |
Heteromer O15514; P13984; P18074; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; | 30-728 | 100.0 | 2×MG; 17×ZN; 1×SF4; |
|
| Cryo-EM structure of the human TFIIH core complex | |
Heteromer P18074; P32780; P51948; Q13888; Q13889; Q6ZYL4; Q92759; | 34-730 | 90.91 | 1×SF4; 6×ZN; |
|
| RNA polymerase II pre-initiation complex with the proximal +1 nucleosome (PIC-Nuc10W) | |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P02281; P06897; P13984; P18074; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; P62799; P84233; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; | 34-730 | 100.0 | 1×SF4; 16×ZN; 1×MG; |
|
| Initial DNA-lesion (AP) binding by XPC and TFIIH complex2 | |
Heteromer P18074; P32780; P41208; P54727; Q01831; Q13888; Q13889; Q6ZYL4; Q92759; | 52-723 | 100.0 | 1×SF4; 5×ZN; 2×CA; |
|
| Initial DNA-lesion (AP) binding by XPC and TFIIH complex 1 | |
Heteromer P18074; P32780; P41208; P54727; Q01831; Q13888; Q13889; Q6ZYL4; Q92759; | 52-723 | 100.0 | 1×SF4; 5×ZN; 2×CA; |
|
| XPC release from Core7-XPA-DNA (Cy5) | |
Heteromer P18074; P23025; P32780; Q01831; Q13888; Q13889; Q6ZYL4; Q92759; | 52-722 | 100.0 | 1×SF4; 6×ZN; |
|
| XPC release from Core7-XPA-DNA (AP) | |
Heteromer P18074; P23025; P32780; Q01831; Q13888; Q13889; Q6ZYL4; Q92759; | 52-722 | 100.0 | 1×SF4; 6×ZN; |
|
| XPA repositioning Core7 of TFIIH relative to XPC-DNA lesion (AP) | |
Heteromer P18074; P23025; P32780; P41208; Q01831; Q13888; Q13889; Q6ZYL4; Q92759; | 52-722 | 100.0 | 1×SF4; 6×ZN; 2×CA; |
|
| Structure of transcribing complex 9 (TC9), the initially transcribing complex with Pol II positione… | |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 51-720 | 100.0 | 17×ZN; 1×SF4; 1×MG; 1×W0F; |
|
| Structure of transcribing complex 5 (TC5), the initially transcribing complex with Pol II positione… | |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 51-720 | 100.0 | 17×ZN; 1×SF4; 1×MG; 1×W0F; |
|
| Structure of transcribing complex 8 (TC8), the initially transcribing complex with Pol II positione… | |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 51-720 | 100.0 | 17×ZN; 1×SF4; 1×MG; 1×W0F; |
|
| Structure of transcribing complex 6 (TC6), the initially transcribing complex with Pol II positione… | |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 51-720 | 100.0 | 17×ZN; 1×SF4; 1×MG; 1×W0F; |
|
| Structure of transcribing complex 3 (TC3), the initially transcribing complex with Pol II positione… | |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 51-720 | 100.0 | 17×ZN; 1×SF4; 1×W0F; 1×MG; |
|
| Structure of transcribing complex 4 (TC4), the initially transcribing complex with Pol II positione… | |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 51-720 | 100.0 | 17×ZN; 1×SF4; 1×MG; 1×W0F; |
|
| XPA repositioning Core7 of TFIIH relative to XPC-DNA lesion (Cy5) | |
Heteromer P18074; P23025; P32780; P41208; Q01831; Q13888; Q13889; Q6ZYL4; Q92759; | 52-721 | 100 | 1×SF4; 6×ZN; 2×CA; |
|
| Structure of transcribing complex 2 (TC2), the initially transcribing complex with Pol II positione… | |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 51-720 | 100.0 | 17×ZN; 1×SF4; 1×W0F; 1×MG; |
|
| Structure of transcribing complex 7 (TC7), the initially transcribing complex with Pol II positione… | |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 51-720 | 100.0 | 17×ZN; 1×SF4; 1×MG; 1×W0F; |
|
| TFIID-based holo PIC on SCP promoter | |
Heteromer A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 51-720 | 100.0 | 17×ZN; 1×SF4; 1×MG; |
|
| RNA polymerase II pre-initiation complex with the distal +1 nucleosome (PIC-Nuc18W) | |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P02281; P06897; P13984; P18074; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; P62799; P84233; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; | 51-720 | 100.0 | 1×SF4; 17×ZN; 1×MG; |
|
| TFIIH in a pre-translocated state (without ADP-BeF3) | |
Heteromer P18074; P29083; P32780; P51948; Q13888; Q13889; Q6ZYL4; Q92759; | 51-720 | 100.0 | 1×SF4; 7×ZN; |
|
| TFIIH in a post-translocated state (with ADP-BeF3) | |
Heteromer P18074; P29083; P32780; P51948; Q13888; Q13889; Q6ZYL4; Q92759; | 51-720 | 100.0 | 1×SF4; 7×ZN; 1×ADP; 1×MG; 1×BEF; |
|
| RNA polymerase II pre-initiation complex with closed promoter DNA in proximal position | |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P13984; P18074; P20226; P29083; P29084; P32780; P35269; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; | 51-720 | 100.0 | 1×SF4; 17×ZN; 1×MG; |
|
| Human Mediator with RNA Polymerase II Pre-initiation complex | |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; A0JLT2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O43513; O60244; O75586; P13984; P18074; P20226; P29083; P29084; P32780; P35269; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q92759; Q96G25; Q96HR3; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9P086; Q9Y3C7; | 51-720 | 100.0 | 1×SF4; 18×ZN; 1×MG; |
|
| XPB-containing part of TFIIH in a post-translocated state (with ADP-BeF3) | |
Heteromer P29083; Q6ZYL4; Q92759; | 51-720 | 100.0 | 1×ADP; 1×MG; 1×BEF; |
|
| RNA polymerase II pre-initiation complex with open promoter DNA | |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P13984; P18074; P20226; P29083; P29084; P32780; P35269; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; | 51-720 | 100.0 | 1×SF4; 15×ZN; 1×ADP; 2×MG; 1×BEF; |
|
| RNA polymerase II pre-initiation complex with closed promoter DNA in distal position | |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P13984; P18074; P20226; P29083; P29084; P32780; P35269; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; | 51-720 | 100.0 | 1×SF4; 17×ZN; 1×MG; |
|
| Initial DNA-lesion (Cy5) binding by XPC and TFIIH | |
Heteromer P18074; P32780; P41208; P54727; Q01831; Q13888; Q13889; Q6ZYL4; Q92759; | 52-720 | 100.0 | 1×SF4; 5×ZN; 2×CA; |
|
| p53-bound TFIID-based holo PIC on HDM2 promoter | |
Heteromer A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 57-721 | 100.0 | 16×ZN; 1×SF4; 1×MG; |
|
| Structure of the human Mediator-bound transcription pre-initiation complex | |
Heteromer A0JLT2; O15514; O43513; O60244; O75448; O75586; P13984; P18074; P19387; P19388; P20226; P24928; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q71SY5; Q92759; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9ULK4; Q9Y2X0; Q9Y3C7; | 64-718 | 100.0 | 2×MG; 16×ZN; 1×SF4; |
|
| Structure of the core TFIIH-XPA-DNA complex | |
Heteromer P18074; P23025; Q13888; Q13889; Q6ZYL4; Q92759; | 71-720 | 100.0 | 1×SF4; 6×ZN; |
|
| Core TFIIH-XPA-DNA complex with modelled p62 subunit | |
Heteromer P18074; P23025; P32780; Q13888; Q13889; Q6ZYL4; Q92759; | 71-720 | 100.0 | 1×SF4; 6×ZN; |
|
| Human holo-PIC in the initial transcribing state | |
Heteromer O15514; P13984; P18074; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; | 244-718 | 100 | 2×MG; 11×ZN; |
|
| Human holo-PIC in the initial transcribing state (no IIS) | |
Heteromer O15514; P13984; P18074; P19387; P19388; P20226; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; | 244-718 | 100 | 2×MG; 10×ZN; |
|
| Human holo-PIC in the closed state | |
Heteromer O15514; P13984; P18074; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; | 244-718 | 100 | 2×MG; 11×ZN; |
|
| Human holo-PIC in the open state | |
Heteromer O15514; P13984; P18074; P19387; P19388; P20226; P23193; P24928; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759; | 244-718 | 100 | 2×MG; 11×ZN; |
|
| Human core TFIIH bound to DNA within the PIC | |
Heteromer P18074; Q13888; Q13889; Q6ZYL4; Q92759; | 244-718 | 100 | |
|
| The cryo-EM structure of human TFIIH | |
Heteromer P18074; Q13888; Q13889; Q6ZYL4; Q92759; | 265-728 | 99.78 | 1×SF4; |
|
| Crystal structure of the C-terminal domain of human XPB/ERCC-3 excision repair protein at 1.80 A | | monomer | 502-730 | 100 | |
|